Abiopharma

New Form 144 - Nuvalent, Inc. Filed: 2025-07-24 AccNo: 0000950170-25-098547 Size: 4 KB

New Form 144 - Nuvalent, Inc. Filed: 2025-07-24 AccNo: 0000950170-25-098546 Size: 4 KB

New Form 4 - DAVITA INC. Filed: 2025-07-24 AccNo: 0000927066-25-000116 Size: 4 KB

New Form 144 - Nuvalent, Inc. Filed: 2025-07-24 AccNo: 0000950170-25-098539 Size: 4 KB

New Form SCHEDULE 13G - Fortive Corp Filed: 2025-07-24 AccNo: 0000905148-25-002550 Size: 45 KB

New Form 4 - Oncology Institute, Inc. Filed: 2025-07-24 AccNo: 0000935836-25-000470 Size: 4 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020270 Size: 5 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020269 Size: 5 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020268 Size: 5 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020267 Size: 5 KB

New Form 3 - Chicago Atlantic BDC, Inc. Filed: 2025-07-24 AccNo: 0000950170-25-098499 Size: 3 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020266 Size: 5 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020265 Size: 5 KB

New Form 4 - SPRUCE BIOSCIENCES, INC. Filed: 2025-07-24 AccNo: 0001415889-25-020261 Size: 5 KB

ImmunoPrecise publie de nouvelles conclusions montrant que LENSai ™ détecte rapidement le risque danticorps anti-médicament, bien avant la phase clinique